Close menu




October 16th, 2020 | 13:19 CEST

Tesla, wallstreet:online, Amazon: Buckle up!

  • Investments
Photo credits: pixabay.com

Today's markets have to accept high losses on a broad front. The reasons cited are, of course, the rising number of infections and the fear of a new lockdown due to the corona pandemic. Despite the strong recovery since March, do we still see a W formation with new lows? That would probably be a disaster for some industries. Others, as absurd as it sounds, would benefit from home offices and boredom within their own four walls. In addition to e-commerce companies like Amazon, online brokers reported rising Q2 figures and a sharp increase in the number of new accounts opened, almost through the entire sector. Generation Z discovered the fun of gambling and, as can be seen in the example of Robinhood in the USA, provided for a high increase in trading activity. You will certainly not lose this if you have to stay at home again.

time to read: 2 minutes | Author: Stefan Feulner
ISIN: DE000A2GS609 , US0231351067 , US88160R1014

Table of contents:


    Profiteer of the crisis

    The financial portal wallstreet:online also benefited significantly. Thanks to strong organic growth and the acquisition of several competitors such as Ariva.de, Finanznachrichten.de, and boersennews.de, the Berliners were able to post a 42.2% increase in revenues to EUR 6.29 million (previous year: EUR 4.42 million). Page impressions rose to 327 million in March 2020, an increase of 106% (last year: 159 million).

    Perfect timing

    The innovative Berliners had a good feeling when they came around the corner with the "Smartbroker" in December 2019. The Smartbroker is part of wallstreet:online capital AG, in which wallstreet:online AG, in turn, holds a 43% stake and is to keep the majority in the future. The goal was to convert the user base that wallstreet:online has built up over the years into actively acting customers.

    Initially, 60,000 accounts were to open in 2020. Still, due to the circumstances mentioned above, the product was in such high demand that the Company has now increased plans by 38.3% to 83,000 accounts.

    Analysts celebrate

    Based on the strong half-year figures, analyst firm GBC has raised its estimates for the current fiscal year and now expects wallstreet:online to achieve consolidated revenues of EUR 29.25 million and EBITDA of EUR 7.30 million. For the following year 2021, GBC expects revenues of EUR 40.60 million and an EBITDA of EUR 11.08 million. The price target of EUR 92.00, which ripped to a new all-time high since last week, was raised to EUR 120 by the analysts. Due to a subsequent and already completed 1:8 stock split, the share price targets must be adjusted accordingly.

    Tripling realistic

    According to a report by "Business Insider Deutschland," the US analyst Pierre Ferragu of New Street Research considers prices of USD 1,200.00 for the electric car manufacturer Tesla to be realistic. It means a tripling of the current price level. His current target price is USD 578.00. For 2026, he believes that Elon Musk's company will generate sales of USD 100 billion and earnings of USD 16.00 per share. The main reason for the rapid increase in sales and profits will be due to the highly anticipated affordable e-cars for the general public. At Battery Day last September, Tesla announced a new model that will be available for USD 25,000.00 in about three years.

    Quick end in Grünheide

    The Europe - Gigafactory in Grünheide in the Oder-Spree district is to be constructed at lightning speed to serve the masses. In the future, 12,000 people are to find work on the 300-hectare site. Also, 500,000 electric cars per year are to come off the assembly line in the first stage from summer 2021 onwards.

    Due to unpaid water bills, however, things will be tight with the schedule of super founder Musk. The Strausberg-Erkner water association turned off the water because Tesla did not pay the money, said an association spokeswoman on Thursday in Strausberg. Tesla received several reminders beforehand with the threat of a shutdown. The period of 14 days had expired. "Tesla is not treated differently from others", the spokeswoman said. The water will be turned on again once the outstanding payment is settled. We assume that the Americans will pay for the costs. Due to the years of leadership over other car manufacturers, this short lockdown should have little impact on the success story.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read